WallStSmart

Park Ha Biological Technology Co., Ltd. (BYAH)vsColgate-Palmolive Company (CL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Colgate-Palmolive Company generates 823530% more annual revenue ($20.80B vs $2.52M). CL leads profitability with a 10.0% profit margin vs 0.0%. CL earns a higher WallStSmart Score of 58/100 (C).

BYAH

Avoid

30

out of 100

Grade: F

Growth: 4.0Profit: 2.5Value: 5.0Quality: 6.0
Piotroski: 3/9Altman Z: -16.66

CL

Buy

58

out of 100

Grade: C

Growth: 4.0Profit: 8.5Value: 4.7Quality: 5.5
Piotroski: 4/9Altman Z: 4.21
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BYAH.

CLUndervalued (+10.1%)

Margin of Safety

+10.1%

Fair Value

$98.54

Current Price

$88.58

$9.96 discount

UndervaluedFair: $98.54Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BYAH2 strengths · Avg: 10.0/10
Price/BookValuation
0.2x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0510/10

Conservative balance sheet, low leverage

CL4 strengths · Avg: 9.3/10
Return on EquityProfitability
36.4%10/10

Every $100 of equity generates 36 in profit

Altman Z-ScoreHealth
4.2110/10

Safe zone — low bankruptcy risk

Market CapQuality
$70.63B9/10

Large-cap with strong market position

Operating MarginProfitability
20.9%8/10

Strong operational efficiency at 20.9%

Areas to Watch

BYAH4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$3.77M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

CL4 concerns · Avg: 3.0/10
PEG RatioValuation
1.584/10

Expensive relative to growth rate

P/E RatioValuation
34.2x4/10

Premium valuation, high expectations priced in

Price/BookValuation
492.1x2/10

Trading at 492.1x book value

EPS GrowthGrowth
-5.9%2/10

Earnings declined 5.9%

Comparative Analysis Report

WallStSmart Research

Bull Case : BYAH

The strongest argument for BYAH centers on Price/Book, Debt/Equity.

Bull Case : CL

The strongest argument for CL centers on Return on Equity, Altman Z-Score, Market Cap.

Bear Case : BYAH

The primary concerns for BYAH are EPS Growth, Market Cap, Profit Margin.

Bear Case : CL

The primary concerns for CL are PEG Ratio, P/E Ratio, Price/Book. Debt-to-equity of 54.99 is elevated, increasing financial risk.

Key Dynamics to Monitor

CL is growing revenue faster at 8.4% — sustainability is the question.

CL generates stronger free cash flow (609M), providing more financial flexibility.

Monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CL scores higher overall (58/100 vs 30/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Park Ha Biological Technology Co., Ltd.

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · China

Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company is headquartered in Wuxi, the People's Republic of China.

Colgate-Palmolive Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Colgate-Palmolive Company is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. It specializes in the production, distribution and provision of household, health care, personal care and veterinary products.

Visit Website →

Want to dig deeper into these stocks?